NEW DELHI : The production-linked incentive (PLI) Scheme for active pharmaceutical ingredients (APIs) or bulk drugs has catalysed investments and helped lower the cost of these key inputs for the Indian drug makers, official
NEW DELHI : Barclays stated recently, that it would be more realistic to expect India’s exports to increase by approximately 12 per cent by 2030. This would equate to a global export share of
